Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

Biotech

Kardigan plans to bring in cozy $320M haul from upcoming IPO

Kardigan has sewn up its IPO plans, with the cardiovascular biotech expecting to bring in a cozy $320 million from its planned Nasdaq listing.

James Waldron Jun 11, 2026 8:14am

Caribou boosts case for off-the-shelf CAR-T v. autologous

Jun 11, 2026 8:00am

How AI is reshaping biopharma decision-making

Brought to you by Clarivate

head to head against clash football helmets fight combat

Takeda’s TYK2 inhibitor beats BMS’ Sotyktu in psoriasis showdown

Jun 11, 2026 7:00am

Managing complexity across biopharma modalities

Brought to you by SK Pharmteco

Fierce Biotech heading to UK amid London Life Sciences Week

Jun 11, 2026 4:57am